Form 4: Verastem Director Exchanges High-Priced Stock Options for New Grant

Michael Kauffman, a director at Verastem, Inc., participated in an option exchange program, cancelling existing stock options with exercise prices above $15.00 and receiving a new grant of options.

Summary

• On March 11, 2024, Verastem director Michael Kauffman exchanged certain unexercised stock options with exercise prices greater than $15.00 for a new option grant.
• Kauffman cancelled options granted between June 2014 and June 2021 with exercise prices ranging from $16.44 to $120.84.
• In return, Kauffman received 16,078 stock options that will vest in two equal installments over two years from March 11, 2024, contingent on continued service as a director or service provider.

Sentiment

Score: 6

Explanation: The document describes a routine transaction (option exchange). It's neither particularly positive nor negative from an investment perspective.

Positives

• The option exchange program may incentivize the director to remain with the company.
• The new options have a lower exercise price than some of the cancelled options, potentially increasing their value to the director.

Future Outlook

The new stock options will vest in two equal installments over a two-year period from March 11, 2024, provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

Industry Context

Option exchange programs are a relatively common practice in corporate governance, often used to refresh incentives for key employees and directors, particularly when the stock price has declined significantly since the original options were granted. This ensures that equity-based compensation remains motivating.

Comparison to Industry Standards

• Option exchange programs are used by companies such as Regeneron Pharmaceuticals Inc. and Biogen Inc. to incentivize key employees and directors.
• The two-year vesting schedule is a standard practice in the industry.

Stakeholder Impact

• The option exchange program could potentially align the director's interests more closely with those of shareholders.
• The exchange has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates